Anhui Anke Biotechnology (Group) Co., Ltd. (SHE: 300009)
China
· Delayed Price · Currency is CNY 7.78
0.00 (0.00%)
Sep 9, 2024, 1:19 PM CST
Anhui Anke Biotechnology (Group) Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 2,873 | 2,861 | 2,327 | 2,160 | 1,694 | 1,701 | Upgrade
|
| Other Revenue | 4.57 | 4.57 | 4.18 | 8.5 | 7.69 | 11.51 | Upgrade
|
| Revenue | 2,877 | 2,866 | 2,331 | 2,169 | 1,701 | 1,713 | Upgrade
|
| Revenue Growth (YoY) | 13.39% | 22.94% | 7.48% | 27.47% | -0.65% | 17.17% | Upgrade
|
| Cost of Revenue | 626.57 | 631.04 | 513.47 | 436.15 | 364.09 | 379.16 | Upgrade
|
| Gross Profit | 2,251 | 2,235 | 1,818 | 1,733 | 1,337 | 1,333 | Upgrade
|
| Selling, General & Admin | 1,070 | 1,030 | 871.18 | 942.68 | 791.65 | 809.51 | Upgrade
|
| Research & Development | 235.14 | 254.68 | 166.01 | 166.54 | 128.76 | 120.09 | Upgrade
|
| Other Operating Expenses | 9.75 | 17.21 | 19.32 | 19.47 | 16.38 | -2.11 | Upgrade
|
| Operating Expenses | 1,336 | 1,322 | 1,062 | 1,133 | 940.64 | 933.91 | Upgrade
|
| Operating Income | 915.11 | 912.92 | 755.7 | 599.3 | 396.69 | 399.46 | Upgrade
|
| Interest Expense | -2.54 | -1.87 | -1.52 | -1.62 | -1.62 | -3.66 | Upgrade
|
| Interest & Investment Income | 11.13 | 5.89 | 9.61 | 11.52 | 13.6 | 9.79 | Upgrade
|
| Currency Exchange Gain (Loss) | 1.3 | 0.86 | 0.06 | 3.92 | -0.07 | -0.03 | Upgrade
|
| Other Non Operating Income (Expenses) | 5.43 | -1.11 | 26.47 | -12.29 | -16.26 | -20.74 | Upgrade
|
| EBT Excluding Unusual Items | 930.42 | 916.69 | 790.32 | 600.83 | 392.35 | 384.82 | Upgrade
|
| Impairment of Goodwill | - | - | - | -322.6 | - | -182.96 | Upgrade
|
| Gain (Loss) on Sale of Investments | -12.37 | -15.44 | 19.86 | -2.24 | -15.42 | -24.82 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.21 | 0.12 | -1.2 | 1.68 | -0.02 | 2.42 | Upgrade
|
| Asset Writedown | -1.55 | -1.49 | -4.47 | -0.84 | -0.03 | -16.05 | Upgrade
|
| Other Unusual Items | 30.72 | 20.05 | 29.34 | 18.28 | 39.27 | - | Upgrade
|
| Pretax Income | 948.44 | 919.93 | 833.85 | 295.12 | 416.14 | 163.41 | Upgrade
|
| Income Tax Expense | 67.94 | 61.34 | 96.19 | 91.73 | 69.6 | 53.02 | Upgrade
|
| Earnings From Continuing Operations | 880.5 | 858.59 | 737.66 | 203.39 | 346.53 | 110.4 | Upgrade
|
| Minority Interest in Earnings | -13.49 | -11.36 | -34.4 | 3.24 | 12.42 | 14.07 | Upgrade
|
| Net Income | 867.01 | 847.23 | 703.26 | 206.63 | 358.96 | 124.47 | Upgrade
|
| Net Income to Common | 867.01 | 847.23 | 703.26 | 206.63 | 358.96 | 124.47 | Upgrade
|
| Net Income Growth | 14.81% | 20.47% | 240.35% | -42.44% | 188.40% | -52.71% | Upgrade
|
| Shares Outstanding (Basic) | 1,668 | 1,661 | 1,635 | 1,589 | 1,632 | 1,660 | Upgrade
|
| Shares Outstanding (Diluted) | 1,668 | 1,661 | 1,635 | 1,589 | 1,632 | 1,660 | Upgrade
|
| Shares Change (YoY) | 1.62% | 1.57% | 2.90% | -2.58% | -1.68% | 5.12% | Upgrade
|
| EPS (Basic) | 0.52 | 0.51 | 0.43 | 0.13 | 0.22 | 0.07 | Upgrade
|
| EPS (Diluted) | 0.52 | 0.51 | 0.43 | 0.13 | 0.22 | 0.07 | Upgrade
|
| EPS Growth | 12.98% | 18.60% | 230.77% | -40.91% | 193.33% | -55.01% | Upgrade
|
| Free Cash Flow | 632.84 | 757.64 | 224.64 | 460.94 | 326.27 | 109.15 | Upgrade
|
| Free Cash Flow Per Share | 0.38 | 0.46 | 0.14 | 0.29 | 0.20 | 0.07 | Upgrade
|
| Dividend Per Share | 0.250 | 0.250 | 0.250 | 0.200 | 0.167 | 0.096 | Upgrade
|
| Dividend Growth | 0% | 0% | 25.00% | 19.98% | 73.28% | 0% | Upgrade
|
| Gross Margin | 78.22% | 77.98% | 77.97% | 79.89% | 78.60% | 77.86% | Upgrade
|
| Operating Margin | 31.80% | 31.86% | 32.42% | 27.63% | 23.32% | 23.33% | Upgrade
|
| Profit Margin | 30.13% | 29.56% | 30.17% | 9.53% | 21.10% | 7.27% | Upgrade
|
| Free Cash Flow Margin | 21.99% | 26.44% | 9.64% | 21.25% | 19.18% | 6.37% | Upgrade
|
| EBITDA | 1,020 | 1,006 | 836.21 | 676.71 | 462.67 | 461.82 | Upgrade
|
| EBITDA Margin | 35.46% | 35.12% | 35.87% | 31.20% | 27.19% | 26.97% | Upgrade
|
| D&A For EBITDA | 105.14 | 93.55 | 80.5 | 77.41 | 65.99 | 62.36 | Upgrade
|
| EBIT | 915.11 | 912.92 | 755.7 | 599.3 | 396.69 | 399.46 | Upgrade
|
| EBIT Margin | 31.80% | 31.86% | 32.42% | 27.63% | 23.32% | 23.33% | Upgrade
|
| Effective Tax Rate | 7.16% | 6.67% | 11.54% | 31.08% | 16.73% | 32.44% | Upgrade
|
| Revenue as Reported | 2,877 | 2,866 | 2,331 | 2,169 | 1,701 | 1,713 | Upgrade
|
| Advertising Expenses | - | 11.12 | 8.24 | 9.96 | 6 | 15.58 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.